ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

VIRI Virios Therapeutics Inc

0,41
-0,0015 (-0,36%)
Zuletzt aktualisiert: 17:36:08
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Virios Therapeutics Inc VIRI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0015 -0,36% 0,41 17:36:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,428 0,4035 0,4288 0,4115
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202415:15GLOBEVirios Therapeutics to Report First Quarter 2024 Financial..
26.3.202414:15GLOBEVirios Therapeutics Announces Publication of International..
08.3.202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06.3.202422:30EDGAR2Form 8-K - Current report
01.3.202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202415:25EDGAR2Form 8-K - Current report
29.2.202415:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
28.2.202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202415:15GLOBEVirios Therapeutics Issues Shareholder Letter..
27.2.202422:15EDGAR2Form 8-K - Current report
02.2.202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
22.1.202415:33EDGAR2Form PRE 14A - Other preliminary proxy statements
22.1.202415:00GLOBEVirios Therapeutics Announces Plans to Advance..
03.1.202413:05EDGAR2Form 8-K - Current report
02.1.202413:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
13.11.202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202313:20EDGAR2Form 8-K - Current report
13.11.202313:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
07.11.202313:29EDGAR2Form 8-K - Current report
06.11.202313:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
02.11.202312:05EDGAR2Form 8-K - Current report
12.10.202313:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
18.9.202313:16EDGAR2Form 8-K - Current report
18.9.202313:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
12.9.202313:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
22.8.202321:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202313:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202313:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
11.8.202314:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202313:15EDGAR2Form 8-K - Current report
10.8.202313:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
09.8.202313:15EDGAR2Form 8-K - Current report
09.8.202313:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
03.8.202322:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
17.7.202313:15EDGAR2Form 8-K - Current report
17.7.202313:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
14.7.202322:25EDGAR2Form 8-K - Current report
14.7.202322:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25.5.202322:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
15.5.202313:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
11.5.202313:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock